2 Milliarden $: Patriot Scientific gegen intel
Seite 65 von 136 Neuester Beitrag: 25.04.21 03:01 | ||||
Eröffnet am: | 18.03.04 14:29 | von: aida73 | Anzahl Beiträge: | 4.387 |
Neuester Beitrag: | 25.04.21 03:01 | von: Silkelwtpa | Leser gesamt: | 355.499 |
Forum: | Hot-Stocks | Leser heute: | 62 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 62 | 63 | 64 | | 66 | 67 | 68 | ... 136 > |
die werden schon net die millionen verbrannt haben :)
Gruß André
Ich warte immer noch auf ein paar anständige Argumente warum man verkaufen sollte - aber da kommt nix.
Angesichts der letzten Tage ist das Volumen doch etwas höher, was für mich als Indikator für einen kleinen "sell of" zählt, himmm unter einen Euro, ist vielleicht möglich, unter einem USD halte ich für unrealistisch.
Also nicht auf das Geschwätz der Waschweiber geben - Ohren still halten, auch wenn mal der eine oder andere "Daimler" aus dem Depot fährt.
viele Grüße Abenteurer
Allerdings ist das schon ne heisse Nummer, short würde ich jetzt sicher nicht stehen wollen! Naja, brennen sollen se wenn die schon nichts verstanden haben!
I stay with the Patriots!
Zu den Deals muss und kann Patriot vielleicht nichts sagen. Dabei so großen Deals meist ein Stillschweigen vereinbart wird. Außerdem wird der Deal ja nicht mit Patriot, sondern mit Alliance geschlossen. Alliance gehört zur Hälfte Patriot, aber ist nicht börsennotiert und somit nicht meldepflichtig. Indirekt haben wir ja etwas über die Summe erfahren, da es ja zwei Dividenden in recht kurzer Zeit gab.
Gruß André
"Ich warte immer noch auf ein paar anständige Argumente warum man verkaufen sollte - aber da kommt nix."
ok dann sag ich dir warum:
wenn du bei 1,88 verkauft hättest und jetzt bei ,92 nur mit der hälfte wieder eingestiegen wärst, hast du wieder die chance wieder 100% zu machen (wenn wieder auf 1,88) ohne irgendein verlustrisiko eunzugehen.
wenn das kein grund ist, eine aktie nicht stur zu halten, sondern auch zu handeln, weiss ich es nicht.
die börse ist ein marktplatz mit angebot und nachfrage, und da kauft und verkauft man.
nicht die news machen den kurs, sondern die nachfrage (manchmal als reaktion auf news, manchal aber auch charttechnisch getrieben oder strategisch siehe hedgefonds.
hat irgendwer evt. neuigkeiten? evt. will ich mir noch ein paar aktien zulegen, aktuell ists ja wieder ganz günstig
Viele Grüße Abenteurer
Wer kalte Füsse bekommt sollte rechtzeitig aussteigen.
Ich für meinen Teil werde meine Anteile verdoppeln.
Gruss
TradeX
hin und her = taschen leer bzw. schlaftabletten und warten ist die startegie von kosto und heller
wobei hin und her = taschen leer nur gilt, wenn du mit verlust verkaufst und wartest, dass du billiger wieder reinkommst
meine ist = gewinne sichern mit stopp loss und auf der watchliste behalten und dann wieder rein
und geh mal auf
http://www.americanbulls.com/...anyTicker=PTSC&MarketTicker=OTC&TYP=S
die fahren doch anscheinend mit ihrer strategie richtig
Patriot Scientific Receives Share of Proceeds from MMP Patent Portfolio Licensing Agreement with Fujitsu; Revenue from Distribution Will Fund Unprecedented 2nd 2006 Dividend, to be Paid April 24
CARLSBAD, Calif.--(BUSINESS WIRE)--April 5, 2006--Patriot Scientific Corporation (OTC Bulletin Board: PTSC) today announced that it has received its share of the distribution of proceeds from a licensing payment made by Fujitsu Limited - announced last month as the latest global system manufacturer to purchase a license to use intellectual property protected by the Moore Microprocessor Patent(TM) (MMP) Portfolio. The amount will be used to fund Patriot Scientific\'s second shareholder dividend of 2006, which will be issued on April 24 to shareholders of record as of March 31, 2006. Patriot Scientific and The TPL Group are co-owners of the MMP Portfolio, which is being exclusively managed by Alliacense, a TPL Group enterprise.
"This distribution to Patriot Scientific substantially increases our pre-dividend cash position and represents another significant milestone in our ongoing effort to realize the monetary value of our portfolio for the benefit of our Company and ultimately our shareholders," said Chairman and CEO David H. Pohl. "It not only provides funding for our second dividend to shareholders in two months - it also represents further validation of our dramatic transition as a company within just the past year. Patriot has changed from formerly being a small, promising yet profitless microprocessor company to one now rapidly receiving recognition as the co-owner of what our advisors tell us is a highly valuable patent portfolio of ubiquitous high-tech intellectual property."
Patriot\'s first-ever cash dividend of $0.02 per share was issued to shareholders on March 22, 2006. Patriot\'s second dividend pay-out - $0.04 per share - will be issued on April 24.
"Even a single dividend is considered virtually unprecedented for microcap firms, particularly companies such as Patriot Scientific that are focused on microprocessor technologies," Pohl pointed out. "There are no other examples we are aware of in which a microcap has issued two dividends within a single quarter -- which is the way our Board of Directors has currently chosen to share the early fruits of our patent portfolio licensing strategy with our shareholders."
In striking this breakthrough licensing agreement for the MMP Portfolio as announced in March, 2006, systems manufacturer Fujitsu joined Casio, Hewlett-Packard, Intel and AMD in licensing Patriot\'s core patents, which impact virtually every microprocessor manufactured since 1994.
The broad range of system-level digital products exploiting MMP Portfolio design techniques - in addition to computers and related hardware - includes consumer electronic products ranging from televisions, digital cameras and portable music players, high-tech medical equipment, office automation products, aerospace and even automotive electronics systems. All of these products are designed with multiple semiconductor devices that use MMP Portfolio technologies.
"It is on this basis, although no assurances can be given, that Patriot anticipates receiving its share of proceeds from further licensing agreements with major technology manufacturers that our contract licensing team is working to achieve in 2006 and succeeding years while the patents remain enforceable," Pohl said.
About the MMP Portfolio
The patent portfolio, marketed as the Moore Microprocessor Patent(TM) Portfolio, contains intellectual property that is jointly owned by publicly held Patriot Scientific Corporation and the privately held TPL Group. The portfolio encompasses seven U.S. patents as well as their European and Japanese counterparts. Both TPL and Patriot assert that their jointly owned patents protect techniques used in designing microprocessors, microcontrollers, Digital Signal Processor (DSPs), embedded processors and System-on-Chip (SoC) implementations. The MMP Portfolio is exclusively managed by Alliacense, a TPL Group enterprise.
About Patriot Scientific
Patriot Scientific (PTSC) has emerged as an effective and dynamic intellectual property licensing Company, developing and marketing innovative and proprietary semiconductor technologies. The company\'s portfolio of proprietary designs encompasses fundamental microprocessor technology, as well as pending patents designed to protect Patriot\'s proprietary technology. Detailed information about Patriot Scientific can be found on the website www.ptsc.com. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at www.hawkassociates.com and www.americanmicrocaps.com. An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/patriot/profile.htm.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the Company\'s cash flow, market acceptance risks, technical development and litigation risks, seasonality and other risk factors detailed in the Company\'s Securities and Exchange Commission filings.
Alliacense, Moore Microprocessor Patent, and MMP are trademarks of Technology Properties Limited (TPL). All other trademarks belong to their respective owners.
Kontakte
Patriot Media Relations, Carlsbad
Attention Group
Daryl Toor, 770-777-9489
dtoor@attentiongroup.com
or
Patriot Investor Relations
Hawk Associates
Frank Hawkins/ Ken AuYeung, 305-451-1888
info@hawkassociates.com
Zentrum für Unternehmensinformationen Notierung/Chart SEC Filings Financials Zu "My Companies" hinzufügen
Diese Meldung drucken Diese Meldung per E-Mail versenden Fenster schließen
Nutzungsbedingungen | © Business Wire 2006
CARLSBAD, Calif.--(BUSINESS WIRE)--April 5, 2006--
Patriot Scientific Corporation (OTC Bulletin Board: PTSC) today announced that it has received its share of the distribution of proceeds from a licensing payment made by Fujitsu Limited - announced last month as the latest global system manufacturer to purchase a license to use intellectual property protected by the Moore Microprocessor Patent(TM) (MMP) Portfolio. The amount will be used to fund Patriot Scientific's second shareholder dividend of 2006, which will be issued on April 24 to shareholders of record as of March 31, 2006. Patriot Scientific and The TPL Group are co-owners of the MMP Portfolio, which is being exclusively managed by Alliacense, a TPL Group enterprise.
"This distribution to Patriot Scientific substantially increases our pre-dividend cash position and represents another significant milestone in our ongoing effort to realize the monetary value of our portfolio for the benefit of our Company and ultimately our shareholders," said Chairman and CEO David H. Pohl. "It not only provides funding for our second dividend to shareholders in two months - it also represents further validation of our dramatic transition as a company within just the past year. Patriot has changed from formerly being a small, promising yet profitless microprocessor company to one now rapidly receiving recognition as the co-owner of what our advisors tell us is a highly valuable patent portfolio of ubiquitous high-tech intellectual property."
Patriot's first-ever cash dividend of $0.02 per share was issued to shareholders on March 22, 2006. Patriot's second dividend pay-out - $0.04 per share - will be issued on April 24.
"Even a single dividend is considered virtually unprecedented for microcap firms, particularly companies such as Patriot Scientific that are focused on microprocessor technologies," Pohl pointed out. "There are no other examples we are aware of in which a microcap has issued two dividends within a single quarter -- which is the way our Board of Directors has currently chosen to share the early fruits of our patent portfolio licensing strategy with our shareholders."
In striking this breakthrough licensing agreement for the MMP Portfolio as announced in March, 2006, systems manufacturer Fujitsu joined Casio, Hewlett-Packard, Intel and AMD in licensing Patriot's core patents, which impact virtually every microprocessor manufactured since 1994.
The broad range of system-level digital products exploiting MMP Portfolio design techniques - in addition to computers and related hardware - includes consumer electronic products ranging from televisions, digital cameras and portable music players, high-tech medical equipment, office automation products, aerospace and even automotive electronics systems. All of these products are designed with multiple semiconductor devices that use MMP Portfolio technologies.
"It is on this basis, although no assurances can be given, that Patriot anticipates receiving its share of proceeds from further licensing agreements with major technology manufacturers that our contract licensing team is working to achieve in 2006 and succeeding years while the patents remain enforceable," Pohl said.
About the MMP Portfolio
The patent portfolio, marketed as the Moore Microprocessor Patent(TM) Portfolio, contains intellectual property that is jointly owned by publicly held Patriot Scientific Corporation and the privately held TPL Group. The portfolio encompasses seven U.S. patents as well as their European and Japanese counterparts. Both TPL and Patriot assert that their jointly owned patents protect techniques used in designing microprocessors, microcontrollers, Digital Signal Processor (DSPs), embedded processors and System-on-Chip (SoC) implementations. The MMP Portfolio is exclusively managed by Alliacense, a TPL Group enterprise.
About Patriot Scientific
Patriot Scientific (PTSC) has emerged as an effective and dynamic intellectual property licensing Company, developing and marketing innovative and proprietary semiconductor technologies. The company's portfolio of proprietary designs encompasses fundamental microprocessor technology, as well as pending patents designed to protect Patriot's proprietary technology. Detailed information about Patriot Scientific can be found on the website www.ptsc.com. Copies of Patriot Scientific press releases, current price quotes, stock charts and other valuable information for investors may be found at www.hawkassociates.com and www.americanmicrocaps.com. An investment profile on Patriot Scientific may be found at http://www.hawkassociates.com/patriot/profile.htm.
Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the Company's cash flow, market acceptance risks, technical development and litigation risks, seasonality and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Alliacense, Moore Microprocessor Patent, and MMP are trademarks of Technology Properties Limited (TPL). All other trademarks belong to their respective owners.
Source: Patriot Scientific Corporation
Schöner Satz.
@mecano Ja, wie gesagt eine Strategie oder Philosophie, meine ist eben die auf den Tag X zu waren, an dem ich Rech bekomme oder mein Geld weg ist.
Ich glaube nicht, dass einen Hin- und Her-Strategie auf Dauer erfolgreich sein kann, an welchen realistischen Faktoren könnte man Kauf oder Verkauf festmachen? Bitte komm mir jetzt nicht mit Widerständen oder 120Tageslinien – das sind für mich keine Argumente, das ist Wahrsagerei oder selbsterfüllte Prophezeiung.
Viele Grüße Abenteurer
liege ich da richtig ?
(Weiter warten auf die Zahlen.)
Ich glaube immer mehr da gibt es Interessen zwischen Himmel und Hölle, die nicht wollen, dass der Kurs unter einen USD fällt.
Regt sich da Widerspruch?
@Der Taipan Ich glaube nicht, sicher haben die viel mehr bezahlt.
2 Cent, 4 Cent ...
Wer kennt sich nochmal mit Folgen und Reihen aus ? ;-)